We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-8.31%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.35B
AUM Growth
+$1.57B
Cap. Flow
+$2.42B
Cap. Flow %
25.92%
Top 10 Hldgs %
31.61%
Holding
370
New
10
Increased
144
Reduced
147
Closed
31

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$109M
2
MSFT icon
Microsoft
MSFT
+$108M
3
CSCO icon
Cisco
CSCO
+$104M
4
NEE icon
NextEra Energy
NEE
+$102M
5
TXN icon
Texas Instruments
TXN
+$87.5M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$23M
2
VTR icon
Ventas
VTR
+$15.8M
3
PG icon
Procter & Gamble
PG
+$5.57M
4
ROP icon
Roper Technologies
ROP
+$4.51M
5
FAST icon
Fastenal
FAST
+$3.9M

Sector Composition

Rank Sector Weight
1 Technology 19.29%
2 Healthcare 18.06%
3 Financials 14.08%
4 Industrials 10.05%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSM icon
201
MSC Industrial Direct
MSM
$7.01B
$1.83M 0.02%
+23,800
New +$1.97M
WST icon
202
West Pharmaceutical
WST
$24.7B
$1.83M 0.02%
18,624
-640
-3% -$69.4K
WAB icon
203
Wabtec
WAB
$50B
$1.8M 0.02%
25,656
-20
-0.1% -$1.75K
ZTS icon
204
Zoetis
ZTS
$31.2B
$1.79M 0.02%
20,875
– –
COHR icon
205
Coherent
COHR
$64.2B
$1.78M 0.02%
54,716
-7,760
-12% -$290K
AMZN icon
206
Amazon
AMZN
$2.94T
$1.75M 0.02%
23,300
+240
+1% +$20K
ORCL icon
207
Oracle
ORCL
$416B
$1.74M 0.02%
38,503
-4,500
-10% -$216K
SON icon
208
Sonoco
SON
$5.78B
$1.69M 0.02%
31,895
+11,306
+55% +$620K
JJSF icon
209
J&J Snack Foods
JJSF
$1.59B
$1.68M 0.02%
11,624
-868
-7% -$132K
ATRI
210
DELISTED
Atrion Corp
ATRI
$1.65M 0.02%
2,223
-184
-8% -$132K
BF.B icon
211
Brown-Forman Class B
BF.B
$13B
$1.65M 0.02%
34,608
– –
XRAY icon
212
Dentsply Sirona
XRAY
$2.76B
$1.56M 0.02%
41,970
-8,230
-16% -$300K
SCL icon
213
Stepan Co
SCL
$1.46B
$1.56M 0.02%
21,096
-1,626
-7% -$132K
NSC icon
214
Norfolk Southern
NSC
$76.8B
$1.56M 0.02%
10,413
+1
+0% +$164
VFC icon
215
VF Corp
VFC
$5.98B
$1.55M 0.02%
23,132
+63
+0.3% +$4.82K
VMI icon
216
Valmont Industries
VMI
$9.58B
$1.54M 0.02%
13,905
-1,095
-7% -$136K
GMED icon
217
Globus Medical
GMED
$10.9B
$1.53M 0.02%
35,303
-2,578
-7% -$129K
VWO icon
218
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$1.53M 0.02%
40,058
+790
+2% +$30.6K
MATW icon
219
Matthews International
MATW
$857M
$1.51M 0.02%
37,246
-2,781
-7% -$118K
JOUT icon
220
Johnson Outdoors
JOUT
$509M
$1.49M 0.02%
25,374
+2,012
+9% +$144K
STI
221
DELISTED
SunTrust Banks, Inc.
STI
$1.49M 0.02%
29,530
+1,185
+4% +$71K
SABR icon
222
Sabre
SABR
$838M
$1.43M 0.02%
66,261
-5,412
-8% -$131K
MA icon
223
Mastercard
MA
$500B
$1.41M 0.02%
7,496
+6
+0.1% +$1.19K
HI
224
DELISTED
Hillenbrand
HI
$1.4M 0.02%
36,870
– –
IBM icon
225
IBM
IBM
$222B
$1.39M 0.01%
12,785
-2,045
-14% -$245K
7 8
9
10 11

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q4 2018 Portfolio in Review

As of Q4 2018, Bahl & Gaynor held 370 positions worth $9.35B, up 20% from $7.78B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor deployed $2.42B of net new capital in Q4 2018, opening 10 new positions and adding to 144 existing holdings. Its largest new stake was Celanese: 21,191 shares worth $1.91M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ventas, an estimated $15.8M trimmed.

  • Bahl & Gaynor's largest Q4 2018 buy was Celanese: 21,191 shares worth $1.91M.
  • Bahl & Gaynor added most to JPMorgan Chase in Q4 2018, an estimated $109M increase.
  • Bahl & Gaynor's biggest Q4 2018 reduction was Ventas, cutting an estimated $15.8M.
  • Bahl & Gaynor fully exited Praxair Inc in Q4 2018, selling an estimated $23M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $9.35B portfolio in Q4 2018.
  • Bahl & Gaynor opened 10 new positions and closed 31 in Q4 2018.
  • Bahl & Gaynor's portfolio value rose 20% quarter-over-quarter to $9.35B.

Based on Bahl & Gaynor's 13F filing for Q4 2018, filed 12 Feb 2019.